Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2008
10/29/2008CN100429208C Process for prepn. of racemic citalopram and/or S-or R-citalopram by separation of mixture of R-and S-citalopram
10/29/2008CN100429206C Benzoxazine derivatives as 5-HT6 modulators and uses thereof
10/29/2008CN100429201C Heterocyclic compounds and methods of use thereof
10/29/2008CN100428959C Process for producing drug ultramicroparticle and apparatus therefor
10/29/2008CN100428956C Use of aza decyl meta pentalkenylone compounds
10/29/2008CN100428942C Heart-nourishing and tranquilizing medicine and its prepn process
10/29/2008CN100428934C Application of cumarin kind compound in preparation of medicine for inducing nerve stem cell orienting differentiation
10/29/2008CN100428933C Use of opc in preparing medicine for treating and preventing senile dementia
10/29/2008CN100428893C Health-care food contg. giant salamander, and its production method
10/28/2008US7442837 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442836 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442807 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
10/28/2008US7442805 Substituted sulfonamide-indoles
10/28/2008US7442792 halogenation of pyrazolo[1,5-a][1,3,5]triazin-4-ol's, with phosphorus oxyhalides, then dehalogenation and amination to yield dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine's, used as corticotropin releasing factor (CRF) receptor antagonists; anxiolytic agents; antidepressants
10/28/2008US7442790 Caspase inhibitors and uses thereof
10/28/2008US7442719 Methods using phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442713 2-thio-substituted imidazole derivatives and their use in pharmaceutics
10/28/2008US7442712 Constrained himbacine analogs as thrombin receptor antagonists
10/28/2008US7442710 Substituted phenyl methanones
10/28/2008US7442708 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia
10/28/2008US7442704 Amide derivatives
10/28/2008US7442703 Piperidine derivatives useful as CCR5 antagonists
10/28/2008US7442699 For treatment of rheumatoid arthritis, inflammatory or autoimmune condition, viral infection, cancer; 4-{[4-(4-chlorophenyl)pyrimidin-2-yl]amino}benzamide
10/28/2008US7442694 Diazabicyclic compounds useful in the treatment of CNS and other disorders
10/28/2008US7442691 Macrocycles useful in the treatment of alzheimer's disease
10/28/2008US7442688 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
10/28/2008US7442546 Method of modulating inflammatory response
10/28/2008US7442386 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies
10/28/2008US7442383 N-methyl D-aspartic acid (NMDA) receptor antagonism; neuroprotection
10/28/2008US7442370 Polymer conjugates of mutated neublastin
10/28/2008US7442368 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation
10/28/2008US7442142 Automatic transmission
10/28/2008CA2524300C Modified-release tablet of bupropion hydrochloride
10/28/2008CA2472107C Dibenzodiazepine derivates, their preparation and use
10/28/2008CA2448735C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
10/28/2008CA2442227C Ccr5 antagonists useful for treating aids
10/28/2008CA2391808C Method for treatment of symptoms of central nervous system disorders
10/28/2008CA2380452C Imidazo-triazine derivatives as ligands for gaba receptors
10/28/2008CA2367003C Peptides useful in treating multiple sclerosis and a pharmaceutical composition comprising the same
10/28/2008CA2275167C The topical use of kappa opioid agonists to treat ocular pain
10/27/2008CA2586748A1 Agents for prophylaxis or treatment of neurological diseases and conditions
10/27/2008CA2585247A1 Agents for prophylaxis or treatment of neurological related diseases and conditions
10/23/2008WO2008128166A1 Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds
10/23/2008WO2008128049A2 Tetrahydrobiopterin compositions and methods of measuring
10/23/2008WO2008127725A1 Compositions and methods for treatment of psychiatric disorders
10/23/2008WO2008127722A1 Methods for treating spinal muscular atrophy using tetracycline compounds
10/23/2008WO2008127618A1 Crystalline and amorphous forms of naltrexone hydrochloride
10/23/2008WO2008127585A1 Substituted furo[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators
10/23/2008WO2008127464A1 Heterocyclic compounds and their methods of use
10/23/2008WO2008127188A1 N-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
10/23/2008WO2008127100A1 Means and methods for counteracting protein aggregation
10/23/2008WO2008126940A1 Novel t cell
10/23/2008WO2008126932A2 Epigenetical regulation of brain plasticity
10/23/2008WO2008126920A1 Remedy for diabetes
10/23/2008WO2008126901A1 Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same
10/23/2008WO2008126886A1 Indole or indoline derivative
10/23/2008WO2008126732A1 Fused bicyclic heteroaryl derivatives
10/23/2008WO2008126693A1 Remedy and diagnostic for mitochondrial dysfunction brain disease
10/23/2008WO2008126367A1 Ataractic agent and functional food
10/23/2008WO2008125891A2 Pyrimidinyl-piperazines useful as dopamine d3 /d2 receptor ligands
10/23/2008WO2008125627A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/23/2008WO2008125600A2 Pyrazole derivatives as p2x7 modulators
10/23/2008WO2008125412A1 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
10/23/2008WO2008125349A1 Spiro-pyrano-pyrazole derivatives
10/23/2008WO2008125348A1 Pyrano-pyrazole-amines
10/23/2008WO2008125337A2 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
10/23/2008WO2008125008A1 Cyclohepta[b]pyridine compounds, preparation method and usage thereof as well as pharmaceutical compositions containing the compounds
10/23/2008WO2008124969A1 Preparation method of rivastigmine and its intermediates
10/23/2008WO2008124931A1 Use of cyclohexanehexol derivatives in the treatment of amyotrophic lateral sclerosis
10/23/2008WO2008124930A1 Use of cyclohexanehexol derivatives for the treatment of polyglutamine diseases
10/23/2008WO2008124929A1 USE OF CYCLOHEXANEHEXOL DERIVATIVES IN THE TREATMENT OF α-SYNUCLEINOPATHIES
10/23/2008WO2008107334A3 Process for the synthesis of glyt-1 inhibitors
10/23/2008WO2008100463B1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
10/23/2008WO2008099210A3 Piperazine derivatives for treatment of ad and related conditions
10/23/2008WO2008099081A3 Novel triazabenzo[α]naphtho[2,l,8-cde]azulene derivatives, method for preparing the same and pharmaceutical compositions containing the same
10/23/2008WO2008090357A3 N, n; -substituted piperazines binding to melanocortin receptor
10/23/2008WO2008070284A3 Amyloid beta peptides and methods of uses thereof
10/23/2008WO2008067121A3 Methods of treating cognitive impairment and dementia
10/23/2008WO2008062296A3 Nop receptor agonists for the treatment of l-dopa induced dyskinesias
10/23/2008WO2008053341A3 Bridged bicyclic indazoles as cannabinoid receptor ligands
10/23/2008WO2008049053A3 Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
10/23/2008WO2008045488A3 Treatment of inflammation, demyelination and neuronal/axonal loss
10/23/2008WO2008029300A3 Methods for treating at least one condition having mt1 receptor, 5ht2b receptor, and l-type calcium channel activity
10/23/2008WO2007148309A3 Compositions and kits comprising a melatonin component and a flavanol component
10/23/2008WO2007148308A3 Compositions and kits comprising a melatonin component and an omega-3-fatty acid component
10/23/2008WO2007134245A3 Elastin-like polymer delivery vehicles
10/23/2008WO2007117438A3 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
10/23/2008US20080263607 Downloading and Transfer of Audio or Video Data from Video Broadcasts
10/23/2008US20080262284 Disposable products ; multilayer; interior and exterior layers forming reservoirs; heat activated adhesives; sealing; colorimetric analysis
10/23/2008US20080262229 Analgesics; pain management
10/23/2008US20080262228 Therapy for central nervous system disorders; Alzheimer's disease; 5-fluoro-8-(4-(4-(6-methoxyquinolin-8-) piperazin-1-yl )piperidin-1-yl)quinoline
10/23/2008US20080262221 (PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES
10/23/2008US20080262205 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease
10/23/2008US20080262091 Analgesic/antinociceptive agents comprising 1-15,000mu g of capsaicin and other capsaicinoids in a vehicle; side effect reduction; neuropathic pain; neurotransmitter-dysregulation syndromes; incapacitation of C-fibers and/or A-delta fibers; denervate edges without eliciting an effect outside the edge
10/23/2008US20080262076 Novel Tetracyclic Tetrahydrofuran Derivatives Containing Cyclic Amine Side Chain
10/23/2008US20080262074 salt forms of [R (R*,R*)]-2-(4-fluorophenyl)- beta , delta -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid or solvates or hydrates thereof, as well as crystalline salts characterized by their X-ray powder diffraction pattern are described
10/23/2008US20080262068 Method of Tonic Treatment With Oxyphenbutazone Derivatives
10/23/2008US20080262065 Novel inhibitors of glutaminyl cyclases
10/23/2008US20080262063 Novel inhibitors of glutaminyl cyclase
10/23/2008US20080262059 AT 1-antagonist vaisertan or a pharmaceutically acceptable salt thereof; and(ii) a NEP inhibitor or a pharmaceutically acceptable salt thereof and optionally a pharmaceutically acceptable carrier and to a method for the treatment or prevention of a condition or diseaseselected from hypertension
1 ... 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 ... 1833